- Home
- DTST vs FBRX Comparison
DTST vs FBRX Comparison
Compare DTST & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- FBRX
- Stock Information
- Founded
- DTST 2001
- FBRX N/A
- Country
- DTST United States
- FBRX United States
- Employees
- DTST N/A
- FBRX N/A
- Industry
- DTST EDP Services
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- FBRX Health Care
- Exchange
- DTST Nasdaq
- FBRX Nasdaq
- Market Cap
- DTST 32.7M
- FBRX 35.3M
- IPO Year
- DTST N/A
- FBRX N/A
- Fundamental
- Price
- DTST $3.64
- FBRX $7.32
- Analyst Decision
- DTST
- FBRX Strong Buy
- Analyst Count
- DTST 0
- FBRX 4
- Target Price
- DTST N/A
- FBRX $77.58
- AVG Volume (30 Days)
- DTST 24.8K
- FBRX 54.4K
- Earning Date
- DTST 03-31-2025
- FBRX 03-31-2025
- Dividend Yield
- DTST N/A
- FBRX N/A
- EPS Growth
- DTST 40.00
- FBRX N/A
- EPS
- DTST 0.07
- FBRX N/A
- Revenue
- DTST $25,371,303.00
- FBRX N/A
- Revenue This Year
- DTST $2.57
- FBRX N/A
- Revenue Next Year
- DTST $11.16
- FBRX N/A
- P/E Ratio
- DTST $51.29
- FBRX N/A
- Revenue Growth
- DTST 1.65
- FBRX N/A
- 52 Week Low
- DTST $3.24
- FBRX $4.11
- 52 Week High
- DTST $8.00
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- DTST 51.15
- FBRX 46.88
- Support Level
- DTST $3.41
- FBRX $7.10
- Resistance Level
- DTST $3.96
- FBRX $9.04
- Average True Range (ATR)
- DTST 0.20
- FBRX 1.27
- MACD
- DTST 0.04
- FBRX 0.42
- Stochastic Oscillator
- DTST 64.91
- FBRX 59.82
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).